Dr. Karine Gabrielian, MD

Dr. Gabrielian practices at Brand Surgical Institute - Glendale (N Brand Blvd) in Glendale, California.

Dr. Gabrielian's NPI, 1740388982, was assigned on September 20, 2006. Dr. Gabrielian graduated from Yerevan State Medical University in 1982. Dr. Gabrielian holds California license A66613.

Dr. Gabrielian's primary practice is Brand Surgical Institute - Glendale (N Brand Blvd), at 1146 North Brand Blvd, Glendale, CA 91202. The practice phone is (818) 265-7722.

Dr. Gabrielian's primary practice is Brand Surgical Institute - Glendale (N Brand Blvd) in Glendale, California. Dmand AI also links Dr. Gabrielian to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gabrielian practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gabrielian's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gabrielian is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gabrielian's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Gabrielian treats.

CMS data shows 6,613 Medicare services from Dr. Gabrielian across 25 procedure codes in 2024, for 816 Medicare patients. Medicare paid $435,953 for them.

CMS counts 816 Medicare patients who saw Dr. Gabrielian in 2024. The largest group is 65 to 74, with 438 patients. 75% of them have arthritis, and 75% have high blood pressure. 92% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gabrielian's median patient age at 70, with 61% women.

In 2024, Dr. Gabrielian wrote 5,559 Medicare Part D claims for 706 patients. 52% of them were for generic drugs. CMS names the drug for 5,459 of them, across 35 drugs with 11 or more claims each, at $722,975 in total drug cost. In 2023, CMS named 5,627 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gabrielian for performance year 2024, reported as part of a group. CMS counts 206 procedures of cataract surgery by Dr. Gabrielian, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Gabrielian. The most frequent topics are Cells, Cultured, Rabbits and Cell Division. Dr. Gabrielian has published most often in Arch Ophthalmol. Dr. Gabrielian's most frequent co-author is Kenneth O. Karp, MD.

CMS Open Payments shows 149 general payments to Dr. Gabrielian from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $1,209.

Dmand AI lists 2 awards for Dr. Gabrielian, most recently Harvey Clein reward in 1998.

Dr. Gabrielian graduated from Yerevan State Medical University in 1982. Dr. Gabrielian is a member of AAO.

Dr. Gabrielian is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.